High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at two doses of long-acting injectable risperidone
(Risperdal Consta). The study will use a usual dose of Risperdal Consta (50 mg given every
two weeks) or a higher dose (75 mg-100 mg given every two weeks) to see which one is better
at improving symptoms of schizophrenia or schizoaffective disorder.
Phase:
Phase 4
Details
Lead Sponsor:
Northwestern University Vanderbilt University Medical Center